Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola major virus strain India-1967

Virus Research

Volumn 34, Issue 3, 1994, Pages 207-236

  Shchelkunov, S N ^a   Blinov, V M ^a   Resenchuk, S M ^a   Totmenin, A V ^a   Olenina, L V ^a   Chirikova, G B ^a   Sandakhchiev, L S ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

Orthopoxvirus; Sequence analysis; Variola virus

Indexed keywords

ARTICLE; CONTROLLED STUDY; INDIA; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMALLPOX VIRUS; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMAL; DNA, VIRAL; GENES, VIRAL; GENOME, VIRAL; HUMAN; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RATS; RECEPTORS, CYTOKINE; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SERINE PROTEINASE INHIBITORS; VACCINIA VIRUS; VARIOLA VIRUS; VIRAL PROTEINS;

ORTHOPOXVIRUS; VACCINIA; VACCINIA VIRUS; VARIOLA; VARIOLA MAJOR VIRUS; VARIOLA VIRUS;

EID: 0028151701     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(94)90125-2     Document Type: Article

References (153)

1. Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus
2. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of viral modulation of the host response to infection
3. Partial deletion of the human host range gene in the attenuated vaccinia virus MVA
4. Regulatory interactions between members of the immunoglobulin superfamily
5. The Chou-Fasman secondary structure prediction method with an extended data base
6. Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions
7. Sequence homologies of diverse length tandem repetitions near ends of vaccinia virus genome suggest unequal crossing over
8. Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain
9. Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon
10. Cytokine (tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus infected human alveolar macrophages
11. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread
12. Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein
13. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene
14. Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen
15. Molecular characterization of the vaccinia virus hemagglutinin gene
16. Neural cell recognition molecule F11: homology with fibronectin type III and immunoglobulin in type C domains
17. Deletion of the vaccinia virus growth factor gene reduces virus virulence
18. Poxvirus pathogenesis
19. The T cell activation antigen Cd27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family
20. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
21. Sequence of the cDNA for the human fibroblast-type interleukin-1 receptor
22. In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals
23. A DNA ligase gene in the Copenhagen strain of vaccinia virus is nonessential for viral replication and recombination
24. Hybridization selection and cell free translation of mRNA encoded within the inverted terminal repetition of the vaccinia virus genome
25. Isolation and characterization of attenuated mutants of vaccinia virus
26. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded- RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2
27. The role of telomeres in poxvirus DNA replication
28. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors
29. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
30. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress
31. Vaccinia virus gene SalF5R is non-essential for virus replication in vitro and in vivo
32. The vaccinia virus 42 kDa envelope protein is required for envelopment and egress of extracellular virus and for virulence
33. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope
34. Orthopoxvirus DNA: a comparison of restriction profiles and maps
35. Human herpesvirus 6 induces interleukin-1β and tumor necrosis factor alpha, but not interleukin-6 in peripheral blood mononuclear cell cultures
36. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression
37. Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2
38. Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo
39. The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity
40. The mouse neuronal cell surface protein F3: a phosphatidylinositol-anchored member of the immunoglobulin superfamily related to chicken contactin
41. Interleukin 1 receptor blockade attenuates the host inflammatory response
42. Localization and sequence of a vaccinia virus gene required for multiplication in human cells
43. The complete DNA sequence of vaccinia virus
44. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor
45. Molecular cloning of a cDNA coding biliary glycoprotein I: Primary structure of a glycoprotein immunogically crossreactive with carcinoembryonic antigen
46. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen
47. Two early vaccinia virus genes encode polypeptides related to protein kinase
48. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinious ORF related to the tumor necrosis factor receptor family
49. Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae
50. Vaccinia virus complement-control protein prevents antigen-dependent complement-enhanced neutralization of infectivity and contributes to virulence
51. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope
52. The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis
53. Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily
54. Expression and structure of the human NGF receptor
55. An update on the vaccinia virus genome
56. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2: mechanisms of rapid viral clearance in immunocompetent mice
57. Vaccinia virus encodes a polypeptide with DNA ligase activity
58. Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells
59. Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents
60. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-γ
61. Gene A32 product of vaccinia virus may be an ATPase involved in viral DNA packaging as indicated by sequence comparisons with other putative viral ATPases
62. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
63. Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily
64. Inhibition of the complement cascade by the major secretory protein of vaccinia virus
65. Molecular cloning of the human transmembrane secretory component (poly-Ig receptor) and its mRNA expression in human tissues
66. cDNA sequences of two inducible T-cell genes
67. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion
68. Cloning and expression of cDNAs for two distinct murine necrosis factor receptores demonstrate one receptor is species specific
69. The vaccinia virus B1R gene product is a serine/threonine protein kinase
70. Conservation and variation in orthopoxvirus genome structure
71. Sequencing the smallpox virus genome
72. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes — a molecule related to nerve growth factor receptor
73. Interleukin 1: more than a mediator between leukocytes
74. Potential virulence determinants in terminal regions of variola smallpox virus genome
75. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes
76. Regulation of complement activity by vaccinia virus complement-control protein
77. A novel IL-1 receptor, cloned from B cells by mammalian expression is expressed in many cell types
78. Antiviral effects of recombinant tumor necrosis factor in vitro
79. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence
80. Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor
81. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin
82. Molecular biology of poxviruses
83. The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity
84. Poxvirus-induced alteration of arachidonate metabolism
85. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus
86. A distinctive family of embryonic protein-tyrosine kinase receptors
87. DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister
88. Polypeptide composition of extracellular enveloped vaccinia virus
89. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus
90. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia
91. Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations
92. Deletion of 55 open reading frames from the termini of vaccinia virus
93. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases
94. The prospects for therapy with tumour necrosis factors and their antagonists
95. Recovery of immunodeficient mice from a vaccinia virus/IL 2 recombinant infection
96. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo
97. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β-converting enzyme
98. Mapping of vaccinia virus genes (a review)
99. Local production of tumour necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo
100. Molecular cloning and expression of a receptor for human tumor necrosis factor
101. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter inducates a region conveying cell type-specific expression
102. Characterization of amalgam: a member of the immunoglobulin superfamily from Drosophila
103. Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants
104. Variola virus does not synthesize interleukin-1 binding protein
105. Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms
106. Ankyrin-like proteins of variola and vaccinia viruses
107. Analysis of the nucleotide sequence of 43 kbp segment of the genome of variola virus India-1967 strain
108. Sequencing of the variola virus genome
109. Nucleotide sequence analysis of variola virus HindIII M. L., I genome fragments
110. Comparison of the genetic maps of variola and vaccinia viruses
111. Structuralfunctional organization of the smallpox virus genome. 1. Cloning of viral DNA HindIII and XhoI fragments and sequencing of HindIII fragments M, L
112. Construction of clonoteques of fragments of smallpox virus DNA and structure-function investigation of viral host range genes
113. Analysis of the nucleotide sequence of 48 kbp of the variola major virus strain India-1967 located on the right terminus of the conservative genome region
114. Nucleotide sequence of the vaccinia virus hemagglutinin gene
115. Vaccinia virus hemagglutinin
116. Cloning of the unterleukin 1 receptor from human T cells
117. Vaccinia virus glycoproteins and immune evasion
118. Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily
119. Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping
120. Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases
121. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors
122. Nucleotide sequence of 42 kbp of vaccinia viris strain WR from near the right inverted terminal repeat
123. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks
124. A cowpox virus gene required for multiplication in Chinese hamster ovary cells
125. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
126. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
127. A family of receptor-linked protein tyrosine phospohatases in humans and Drosophila
128. A new nember of the immunoglobulin in superfamily that has a cytoplasmic region homologous to the leukocyte common antigen
129. Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins
130. Using hemorrage determing gene as phenotipic marker for construction of hybrid vaccinia virus variants
131. Vaccinia virus encodes an essential gene with strong homology to protein kinases
132. An orthopoxvirus serpin-like gene controls the ability of infected cells to fuse
133. Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus
134. Tumorigenic poxviruses: Analysis of viral DNA sequences implicated in the tumoregenicity of Shope fibroma virus and malignant rabbit virus
135. Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome
136. Myxoma virus expresses secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence
137. Encoding of a homolog of IFN-α receptor by myxoma virus
138. Production of IL-1 and tumor necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus
139. Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene
140. Complete nucleotide sequences of two agjacent early vaccinia virus genes located within the inverted terminal repetition
141. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
142. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase
143. Biogenesis of poxviruses: genetically controlled modifications of structural and functional components of the plasma membrane
144. Multiple mechanisms of protein insertion into and across membranes
145. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-γ monoclonal antibody blocks generation of virus-specific cytotoxic T-lymphocytes and virus elimination
146. HindIII and SstI restriction sites mapped on rabbit poxvirus and vaccinia virus DNA
147. Inverted terminal repeats in rabbit poxvirus and vaccinia virus DNA
148. Deletion of the vaccinia virus B5R gene encoding a 42 kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination
149. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
150. The Global Eradication of Smallpox. Final Report of the Global Commission for the Certification of Smallpox Eradication
151. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes
152. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell fusion